Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04374630
Title Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian (PROFECTA-II)
Acronym PROFECTA-II
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Laekna Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.